{"id":"https://openalex.org/W3019818403","doi":"https://doi.org/10.1021/acs.jmedchem.9b02035","title":"Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase","display_name":"Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase","publication_year":2020,"publication_date":"2020-04-27","ids":{"openalex":"https://openalex.org/W3019818403","doi":"https://doi.org/10.1021/acs.jmedchem.9b02035","mag":"3019818403","pmid":"https://pubmed.ncbi.nlm.nih.gov/32338514"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.9b02035","doi":"https://doi.org/10.1021/acs.jmedchem.9b02035","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.9b02035","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103032170","display_name":"Volker Schulze","orcid":"https://orcid.org/0000-0002-0158-1789","observed_orcids":["https://orcid.org/0000-0002-0158-1789"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Volker K. Schulze","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0002-0158-1789","affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034559941","display_name":"Ulrich Klar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulrich Klar","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087983820","display_name":"Dirk Kosemund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dirk Kosemund","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064749364","display_name":"Antje Margret Wengner","orcid":"https://orcid.org/0009-0009-5772-1945","observed_orcids":["https://orcid.org/0009-0009-5772-1945"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Antje M. Wengner","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040107084","display_name":"Gerhard Siemeister","orcid":"https://orcid.org/0000-0002-4712-0531","observed_orcids":["https://orcid.org/0000-0002-4712-0531"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerhard Siemeister","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028760686","display_name":"Detlef St\u00f6ckigt","orcid":"https://orcid.org/0009-0003-6406-7028","observed_orcids":["https://orcid.org/0009-0003-6406-7028"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Detlef Sto\u0308ckigt","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032703270","display_name":"Roland Neuhaus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Roland Neuhaus","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084853335","display_name":"Philip Lienau","orcid":"https://orcid.org/0000-0002-6048-4559","observed_orcids":["https://orcid.org/0000-0002-6048-4559"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Philip Lienau","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061144568","display_name":"Benjamin Bader","orcid":"https://orcid.org/0000-0002-5299-396X","observed_orcids":["https://orcid.org/0000-0002-5299-396X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Benjamin Bader","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091879269","display_name":"Stefan Prechtl","orcid":"https://orcid.org/0000-0002-4115-2188","observed_orcids":["https://orcid.org/0000-0002-4115-2188"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stefan Prechtl","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083840314","display_name":"Simon J. Holton","orcid":"https://orcid.org/0000-0002-1315-5752","observed_orcids":["https://orcid.org/0000-0002-1315-5752"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Simon J. Holton","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039089017","display_name":"Hans Briem","orcid":"https://orcid.org/0000-0002-8498-2448","observed_orcids":["https://orcid.org/0000-0002-8498-2448"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hans Briem","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003860053","display_name":"Tobias Marquardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tobias Marquardt","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 42113 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 42113 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014939457","display_name":"Hartmut Schirok","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hartmut Schirok","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 42113 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 42113 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031243988","display_name":"Rolf Jautelat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Rolf Jautelat","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 42113 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 42113 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056088765","display_name":"Rolf Bohlmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Rolf Bohlmann","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Duy Nguyen","orcid":"https://orcid.org/0000-0002-4534-745X","observed_orcids":["https://orcid.org/0000-0002-4534-745X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Duy Nguyen","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0002-4534-745X","affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073508039","display_name":"Amaury E. Fern\u00e1ndez\u2010Montalv\u00e1n","orcid":"https://orcid.org/0000-0001-9156-0000","observed_orcids":["https://orcid.org/0000-0001-9156-0000"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Amaury E. Ferna\u0301ndez-Montalva\u0301n","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0001-9156-0000","affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088384184","display_name":"Ulf B\u00f6mer","orcid":"https://orcid.org/0009-0004-7147-039X","observed_orcids":["https://orcid.org/0009-0004-7147-039X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulf Bo\u0308mer","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010319500","display_name":"Uwe Eberspaecher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Uwe Eberspaecher","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074030846","display_name":"Michael Br\u00fcning","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Bru\u0308ning","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061961549","display_name":"Olaf D\u00f6hr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Olaf Do\u0308hr","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000013392","display_name":"Marian Raschke","orcid":"https://orcid.org/0000-0001-7180-8486","observed_orcids":["https://orcid.org/0000-0001-7180-8486"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marian Raschke","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048269157","display_name":"Bertolt Kreft","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bertolt Kreft","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009359386","display_name":"Dominik Mumberg","orcid":"https://orcid.org/0000-0002-6670-1497","observed_orcids":["https://orcid.org/0000-0002-6670-1497"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dominik Mumberg","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051451842","display_name":"Karl B. Ziegelbauer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Karl Ziegelbauer","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103115056","display_name":"Michael Brands","orcid":"https://orcid.org/0000-0002-9106-3327","observed_orcids":["https://orcid.org/0000-0002-9106-3327"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Brands","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044740532","display_name":"Franz von Nussbaum","orcid":"https://orcid.org/0000-0001-7188-7364","observed_orcids":["https://orcid.org/0000-0001-7188-7364"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Franz von Nussbaum","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031012457","display_name":"Marcus Koppitz","orcid":"https://orcid.org/0000-0003-3943-9291","observed_orcids":["https://orcid.org/0000-0003-3943-9291"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Marcus Koppitz","raw_affiliation_strings":["Bayer AG , , ,","Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , ,","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031012457","https://openalex.org/A5103032170"],"corresponding_institution_ids":["https://openalex.org/I67348948"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":3.2016,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.93669028,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"63","issue":"15","first_page":"8025","last_page":"8042"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.1881999969482422,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triazolopyridines","display_name":"triazolopyridines","score":0.8050000071525574},{"id":"https://openalex.org/keywords/aneuploidy","display_name":"aneuploidy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/mitotic-cell-death","display_name":"mitotic cell death","score":0.7129999995231628},{"id":"https://openalex.org/keywords/metabolic-stability","display_name":"metabolic stability","score":0.6010000109672546},{"id":"https://openalex.org/keywords/hit-optimization","display_name":"hit optimization","score":0.7059999704360962},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.6539999842643738},{"id":"https://openalex.org/keywords/in-vivo-antitumor-efficacy","display_name":"in vivo antitumor efficacy","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C175732170","wikidata":"https://www.wikidata.org/wiki/Q9064829","display_name":"Spindle checkpoint","level":5,"score":0.6857207417488098},{"id":"https://openalex.org/C93304396","wikidata":"https://www.wikidata.org/wiki/Q14763008","display_name":"Mitosis","level":2,"score":0.6626346111297607},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5201871395111084},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5167505145072937},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5057528018951416},{"id":"https://openalex.org/C50001416","wikidata":"https://www.wikidata.org/wiki/Q17861750","display_name":"CHEK1","level":5,"score":0.4887213706970215},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4745403528213501},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.4728403687477112},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.46476754546165466},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.44647350907325745},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.44607311487197876},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.42602306604385376},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4062890410423279},{"id":"https://openalex.org/C47432576","wikidata":"https://www.wikidata.org/wiki/Q918594","display_name":"Spindle apparatus","level":4,"score":0.38466742634773254},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33812132477760315},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29925116896629333},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2986186146736145},{"id":"https://openalex.org/C85813293","wikidata":"https://www.wikidata.org/wiki/Q188909","display_name":"Cell division","level":3,"score":0.24497297406196594},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21314099431037903},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16214501857757568}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008941","descriptor_name":"Spindle Apparatus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008941","descriptor_name":"Spindle Apparatus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017434","descriptor_name":"Protein Structure, Tertiary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019073","descriptor_name":"HT29 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D059566","descriptor_name":"M Phase Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D059566","descriptor_name":"M Phase Cell Cycle Checkpoints","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.jmedchem.9b02035","doi":"https://doi.org/10.1021/acs.jmedchem.9b02035","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.9b02035","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:32338514","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32338514","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:helmholtz.HZB:107323","doi":null,"is_oa":false,"landing_page_url":"https://www.helmholtz-berlin.de/pubbin/oai_publication?VT=1&ID=107323","pdf_url":null,"source":{"id":"https://openalex.org/S4306402598","display_name":"HZB Repository (Helmholtz-Zentrum Berlin f\u00fcr Materialien und Energie GmbH (HZB))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I3018134672","host_organization_name":"Helmholtz Munich","host_organization_lineage":["https://openalex.org/I3018134672"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Medicinal Chemistry 63 2020 , p. 8025 8042","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W94724789","https://openalex.org/W1604407404","https://openalex.org/W1967234247","https://openalex.org/W1977363854","https://openalex.org/W2007472864","https://openalex.org/W2008312146","https://openalex.org/W2009502142","https://openalex.org/W2062458432","https://openalex.org/W2102805328","https://openalex.org/W2106876296","https://openalex.org/W2108141991","https://openalex.org/W2108921801","https://openalex.org/W2114688504","https://openalex.org/W2117692326","https://openalex.org/W2211768750","https://openalex.org/W2263936419","https://openalex.org/W2332976074","https://openalex.org/W2413557253","https://openalex.org/W2519427975","https://openalex.org/W2593981338","https://openalex.org/W2616655501","https://openalex.org/W2886191744"],"related_works":["https://openalex.org/W2897057643","https://openalex.org/W2477963099","https://openalex.org/W4362638986","https://openalex.org/W2263936419","https://openalex.org/W4240055576","https://openalex.org/W2332976074","https://openalex.org/W2936572087","https://openalex.org/W2741564885","https://openalex.org/W2144015247","https://openalex.org/W2073021178"],"abstract_inverted_index":{"Abstract":[0],"Inhibition":[1],"of":[2,16,30,71,79,110,134],"monopolar":[3],"spindle":[4],"1":[5],"(MPS1)":[6],"kinase":[7],"represents":[8],"a":[9],"novel":[10],"approach":[11],"to":[12,51,115,130],"cancer":[13],"treatment:":[14],"instead":[15],"arresting":[17],"the":[18,49,60,72,76,80,94,108,111,131],"cell":[19,40],"cycle":[20],"in":[21,37,93,152,154],"tumor":[22],"cells,":[23],"cells":[24],"are":[25],"driven":[26],"into":[27],"mitosis":[28],"irrespective":[29],"DNA":[31],"damage":[32],"and":[33,39,65,120,123,149],"unattached/misattached":[34],"chromosomes,":[35],"resulting":[36],"aneuploidy":[38],"death.":[41],"Starting":[42],"points":[43],"for":[44],"our":[45],"optimization":[46],"efforts":[47],"with":[48,146],"goal":[50],"identify":[52],"MPS1":[53,135],"inhibitors":[54],"were":[55],"two":[56,112],"HTS":[57,81],"hits":[58],"from":[59,101],"distinct":[61],"chemical":[62],"series":[63,74,85,99,114],"\u201ctriazolopyridines\u201d":[64],"\u201cimidazopyrazines\u201d.":[66],"The":[67,83],"major":[68],"initial":[69],"issue":[70],"triazolopyridine":[73],"was":[75],"moderate":[77],"potency":[78],"hits.":[82],"imidazopyrazine":[84],"displayed":[86],"more":[87],"than":[88],"10-fold":[89],"higher":[90],"potencies;":[91],"however,":[92],"early":[95],"project":[96],"phase,":[97],"this":[98],"suffered":[100],"poor":[102],"metabolic":[103],"stability.":[104],"Here,":[105],"we":[106],"outline":[107],"evolution":[109],"hit":[113],"clinical":[116,127],"candidates":[117,128],"BAY":[118,121],"1161909":[119],"1217389":[122],"reveal":[124],"how":[125],"both":[126],"bind":[129],"ATP":[132],"site":[133],"kinase,":[136],"while":[137],"addressing":[138],"different":[139,142],"pockets":[140],"utilizing":[141],"binding":[143],"interactions,":[144],"along":[145],"their":[147],"synthesis":[148],"preclinical":[150],"characterization":[151],"selected":[153],"vivo":[155],"efficacy":[156],"models.":[157]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2020-05-01T00:00:00"}